[ad_1] Cepter Biopartners’ Alvin Stern (center), managing partner, with Prism Capital Partners’ Eugene Diaz (left) and Edwin Cohen, principal partners Science & Technology On Sep 8, 2023 The bioscience synergy…
[ad_1] Cepter Biopartners’ Alvin Stern (center), managing partner, with Prism Capital Partners’ Eugene Diaz (left) and Edwin Cohen, principal partners Science & Technology On Sep 8, 2023 The bioscience synergy…